591
Views
0
CrossRef citations to date
0
Altmetric
Meningococcal

Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2288389 | Received 04 Jul 2023, Accepted 23 Nov 2023, Published online: 18 Dec 2023

References

  • Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37:2768–6. doi:10.1016/j.vaccine.2019.04.020.
  • Ministerio de Salud Argentina. Boletín epidemiológico nacional. Número 657. 2023 [accessed 2023 Aug 31]. https://bancos.salud.gob.ar/sites/default/files/2023-06/BEN%20657_SE23_2023.pdf.
  • Pardo de Santayana C, Tin Tin Htar M, Findlow J, Balmer P. Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review. Epidemiol Infect. 2023;151:e57. doi:10.1017/S0950268823000328.
  • Gabastou J-M, Agudelo CI, Brandileone MC, Realpe ME, de Oliveira L, de Lemos APS, Valera D, Informe Regional de Sireva II 2007. Datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasores. Washington (DC): Organización Panamericana de la Salud; 2008 [accessed 2023 Jun 2]. https://www.paho.org/es/node/32048.
  • Gomez JA, Wetzler Malbran P, Vidal G, Seoane M, Giglio ND. Estimation of the real burden of invasive meningococcal disease in Argentina. Epidemiol Infect. 2019;147:e311. doi:10.1017/S0950268819002024.
  • Ministerio de Salud Argentina. Fundamentos de la introducción de la vacuna tetravalente (ACYW) conjugada contra el meningococo al Calendario Nacional de Inmunizaciones. 2017 [accessed 2023 Sep 6]. https://bancos.salud.gob.ar/recurso/lineamientos-tecnicos-vacuna-meningococo.
  • Ministerio de Salud Argentina. Huéspedes especiales: Estrategia de vacunación contra meningococo de Argentina. 2020 [accessed 2023 Sep 6]. https://bancos.salud.gob.ar/recurso/huespedes-especiales-estrategia-de-vacunacion-contra-meningococo-de-argentina.
  • Biolchi A, De Angelis G, Moschioni M, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, Claus H, Gorla MCO, et al. Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates. Vaccine. 2020;38(47):7542–50. doi:10.1016/j.vaccine.2020.09.050.
  • Biolchi A, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, Claus H, Gorla MCO, Hong E, Lemos APS, et al. 4CMenB immunization induces serum bactericidal antibodies against non-serogroup B meningococcal strains in adolescents. Infect Dis Ther. 2021;10(1):307–16. doi:10.1007/s40121-020-00370-x.
  • Fazio C, Biolchi A, Neri A, Tomei S, Vacca P, Ambrosio L, Palmieri A, Mori E, La Gaetana R, Pizza M, et al. Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy. Hum Vaccin Immunother. 2021;17:2225–31. doi:10.1080/21645515.2020.1855951.
  • Babraham Bioinformatics. FastQC; 2010 [accessed 2022 Nov 25]. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
  • Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13:e1005595. doi:10.1371/journal.pcbi.1005595.
  • Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.Org website and their applications [version 1; peer review: 2 approved]. Wellcome Open Res. 2018 Sep 24;3:124. doi:10.12688/wellcomeopenres.14826.1.
  • Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, Brunelli B, Pieri A, Santini L, Savino S, et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med. 2003;197:789–99. doi:10.1084/jem.20021911.
  • Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Arico B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, et al. NadA, a novel vaccine candidate of Neisseria meningitidis. J Exp Med. 2002;195:1445–54. doi:10.1084/jem.20020407.
  • Bambini S, De Chiara M, Muzzi A, Mora M, Lucidarme J, Brehony C, Borrow R, Masignani V, Comanducci M, Maiden MC, et al. Neisseria adhesin a variation and revised nomenclature scheme. Clin Vaccine Immunol. 2014;21(7):966–71. doi:10.1128/CVI.00825-13.
  • Viviani V, Biolchi A, Pizza M. Synergistic activity of antibodies in the multicomponent 4CMenB vaccine. Expert Rev Vaccines. 2022;21:645–58. doi:10.1080/14760584.2022.2050697.
  • Ladhani SN, Giuliani MM, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J, Findlow J, Ramsay ME, Borrow R. Effectiveness of meningococcal B vaccine against endemic hypervirulent Neisseria meningitidis W strain, England. Emerg Infect Dis. 2016;22:309–11. doi:10.3201/eid2202.150369.
  • Domnich A, Gasparini R, Amicizia D, Boccadifuoco G, Giuliani MM, Panatto D. Meningococcal antigen typing system development and application to the evaluation of effectiveness of meningococcal B vaccine and possible use for other purposes. J Immunol Res. 2015;2015:353461. doi:10.1155/2015/353461.
  • Rodrigues CMC, Jolley KA, Smith A, Cameron JC, Feavers IM, Maiden MCJ. Meningococcal deduced vaccine antigen reactivity (MenDevar) index: a rapid and accessible tool that exploits genomic data in public health and clinical microbiology applications. J Clin Microbiol. 2020;59(1):e02161–20. doi:10.1128/JCM.02161-20.
  • Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, Vazquez JA, Taha MK, Ceyhan M, Efron AM, et al. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015;71:544–52. doi:10.1016/j.jinf.2015.07.007.